A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)

ClinicalTrials.gov ID: NCT06794541

Public ClinicalTrials.gov record NCT06794541. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 20, 2026, 4:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Intravenous Eravacycline in Pediatric Patients From 8 Years to Less Than 18 Years of Age With Complicated Intra-abdominal Infections (cIAI)

Study identification

NCT ID: NCT06794541
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Tetraphase Pharmaceuticals, Inc; Industry
Enrollment: 35 participants

Conditions and interventions

Conditions

Complicated Intra-abdominal Infections (cIAI)

Interventions

IV Eravacycline 1.5mg/kg Drug
IV Eravacycline 2mg/kg Drug

Drug

Eligibility (public fields only)

Age range: 8 Years to 17 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 21, 2025
Primary completion: Feb 16, 2029
Completion: Mar 18, 2029
Last update posted: May 4, 2026

2025 – 2029

United States locations

U.S. sites: 5
U.S. states: 4
U.S. cities: 5

Facility	City	State	ZIP	Site status
UCLA Ronald Reagan University of California Los Angeles Medical Center	Los Angeles	California	90095	Recruiting
Children's Hospital of Orange County	Orange	California	92868	Recruiting
Ann and Robert H Lurie Children's Hospital of Chicago	Chicago	Illinois	60611	Recruiting
Children's Hospital of LSU Health Sciences Center Shreveport	Shreveport	Louisiana	71101	Recruiting
West Virginia University Medicine Children's Hospital	Morgantown	West Virginia	26506	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06794541, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 4, 2026 · Synced May 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06794541 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →